NEW YORK (GenomeWeb) – Genomic Health reported after the close of the market Tuesday that its third quarter revenues increased 6 percent year over year, driven by a 17 percent jump in tests delivered in the quarter.

The Redwood City, California-based molecular diagnostics firm reported total revenues of $73.6 million for the three months ended Sept. 30 compared to $69.1 million for the third quarter of 2014. It beat analysts' consensus estimate of $73.1 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The president of France's National Research Agency has resigned, according to Nature News.

A senator wants a "right-to-try" provision in the US Food and Drug Administration funding bill, but an ethicist says at Stat News that it would undermine the role of clinical trials.

In PNAS this week: red algae Porphyra umbicalis genome, deep neural network model for sequencing peptides, and more.

The Guardian's Barbara Ellen has tried out some DNA testing services to see whether they provide valuable information.